Publications
2023
Ugolini A., Vecchio D., Scarpelli R., Grimaldi B.
A new class of autophagy inhibitors for the treatment of cancer (P36)- September 10-13, 2023, Cambridge (United Kingdom)
XXII Medicinal Chemistry Symposium - SCI / RSC
Poster
Conference
2023
Demuro S., Di Martino R.M.C., Sauvey C., Tripathi S.K., Ortega J. A., Russo D., Penna I., Myers S. H., Bandiera T., Girotto S., Abagyan R., Cavalli A.
Design and synthesis of triple protein kinase inhibitors: paving the way towards novel CNS tools to reverse the aberrant tau phosphorylation
ACS Spring 2023 meeting
Poster
Conference
2023
Palomba M., Vecchio D., Allavena G., Capaccio V., De Mei C., Scarpelli R., Grimaldi B.
Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy
Journal of Medicinal Chemistry
2023
Scarpelli R., Palomba M., Vecchio D., Ottonello G., Mandrup Bertozzi S., Summa M., Armirotti A., Bertorelli R., De Mei C., Grimaldi B.
Identification of a dual REV-ERBβ and autophagy inhibitor with in vivo anticancer efficacy (P222)- September 3-7, 2023, Zagreb (Croatia)
IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Poster
Conference
2023
Palomba M., Vecchio D., Allavena G., Capaccio V., De Mei C., Scarpelli R., Grimaldi B.
Lead optimization of a class of dual REV_ERB and autophagy inhibitors with in vivo anticancer efficacy (P45)- September 10-13, 2023, Cambridge (United Kingdom)
XXII Medicinal Chemistry Symposium - SCI / RSC
Poster
Conference
2023
Scarpelli R., Palomba M., Vecchio D., Allavena G., Capaccio V., De Mei C., Grimaldi B.
Lead optimization of the diarylalkyl amine series as dual REV_ERB and autophagy inhibitors with in vivo anticancer efficacy (P83)- September 17-20, 2023, Chieti (Italy)
XXVIII National Meeting on Medicinal Chemistry
Poster
Conference
2022
Ugolini A., Mongiardini V., Vecchio D., Scarpelli R., Grimaldi B.
Bactericidal-Autophagy Inhibitors to Treat Recurring Uropathogenic Infections and Cancer (P033). IX EFMC-YMCS 2022, September 8-9, 2022 - Nice (France)
EFMC Young Medicinal Chemists' Symposium
Poster
Conference
2022
Ugolini A., Mongiardini V., Vecchio D., Scarpelli R., Grimaldi B.
Bactericidal-Autophagy Inhibitors to Treat Recurring Uropathogenic Infections and Cancer (P209). XXVII EFMC-ISMC 2022, September 4-8, 2022 - Nice (France)
EFMC International Symposium on Medicinal Chemistry
Poster
Conference
2022
Orioli R., Marotta G., Russo D., Penna I., Rosini M., Ortega J.A., Minarini A.
DESIGN AND SYNTHESIS OF AMMINOTIAZOLE DERIVATIVES AS DUAL LIGANDS TO GSK-3B AND FYN IN THE STUDY OF NEURODEGENERATIVE DISEASES
XXI Giornata della Chimica dell'Emilia Romagna (Bologna)
Poster
Conference
2022
Demuro S., Di Martino R.M.C., Ortega J.A., Sauvey C., Shi D., Tripathi S., Balboni B., Girotto S., Russo D., Penna I., Bandiera T., Ballatore C., Abagyan R., Cavalli A.
Development of multitarget-directed ligands (MTDLs) protein kinases inhibitors to tackle central nervous system (CNS)-related disorders
ACS Spring 2022 meeting
Abstract Report
Conference
2022
Mazzarella M.A., Berti F., Russo D., Penna I., Bottegoni G., Reggiani A., Bertozzi F., Bandiera T.
Identification of dual inhibitors to hit inflammation and neurodegeneration for multiple sclerosis therapy
European School of Medicinal Chemistry, 41st Advanced Course of Medicinal Chemistry and Seminar for PhD students
Poster
Conference
2022
Balboni B., Tripathi S.K., Veronesi M., Russo D., Penna I., Giabbai B., Bandiera T., Storici P., Girotto S., Cavalli A.
Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays
International Journal of Molecular Sciences, vol. 23, (no. 7)
2022
Greco R., Demartini C., Zanaboni A.M., Francavilla M., Reggiani A., Realini N., Scarpelli R., Piomelli D., Tassorelli C.
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
Journal of Headache and Pain, vol. 23, (no. 1)